Skip to content
Rare Disease Tracker
Most Favored Nation Tracker
Rare Disease Tracker
Most Favored Nation Tracker
Methodology
All entries for: Gritgen Therapeutics Co.
December 13, 2025
Gritgen Therapeutics Co.
Orphan Drug Designation
FDA orphan drug designation: treatment of phenylketonuria
Disease Area:
Rare Diseases
Source
Scroll to Top